Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX STOCKHOLM  >  Getinge    GETI B   SE0000202624

GETINGE

(GETI B)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Omx Stockholm
02/10/2020 02/11/2020 02/12/2020 02/13/2020 02/14/2020 Date
172.15(c) 171.35(c) 171(c) 168.9(c) 171.75(c) Last
576 872 581 428 509 746 742 101 554 225 Volume
-0.23% -0.46% -0.20% -1.23% +1.69% Change
More quotes
Financials (SEK)
Sales 2020 27 948 M
EBIT 2020 3 069 M
Net income 2020 1 738 M
Debt 2020 10 764 M
Yield 2020 1,22%
Sales 2021 28 965 M
EBIT 2021 3 449 M
Net income 2021 2 106 M
Debt 2021 9 301 M
Yield 2021 1,47%
P/E ratio 2020 27,9x
P/E ratio 2021 23,0x
EV / Sales2020 2,06x
EV / Sales2021 1,94x
Capitalization 46 779 M
More Financials
Company
Getinge is the world's leader in producing and marketing medical equipment intended to health care facilities (clinics, hospitals, rest homes, etc.). Net sales break down by family of products as follows: - medical systems (53.8%): equipment for operating rooms (primarily tables and lighting... 
More about the company
Surperformance© ratings of Getinge
Trading Rating : Investor Rating :
More Ratings
Latest news on GETINGE
02/12GETINGE : Maria Grehagen Hedberg, deputy representative on Getinge's board, has ..
PU
02/04GETINGE : Medical devices from Mateusz' employer saved his triplets' life
PU
01/30GETINGE FULL YEAR REPORT 2019 : Continued growth, higher margins and strengthene..
AQ
01/30GETINGE : 4th quarter results
CO
01/20GETINGE : is announcing a voluntary recall - correction of 46-Series Washer Disi..
PU
01/15GETINGE ANNOUNCES ITS FY REPORT 2019 : 00 CET followed by a conference call at 1..
AQ
01/03GETINGE : completes acquisition of Applikon Biotechnology B.V.
AQ
2019GETINGE : 4th quarter report
CO
2019GETINGE : Press release
AQ
2019GETINGE : to acquire Applikon Biotechnology B.V., a leading company in the fast ..
AQ
2019GETINGE : is announcing a medical device recall/field action related to packagin..
AQ
2019GETINGE : is announcing a voluntary recall of Reinforced Introducer Sets sold as..
AQ
2019GETINGE : is announcing a voluntary recall of the ROTAFLOW drive unit
AQ
2019GETINGE : enters into additional Settlement Agreements with authority in Brazil
AQ
2019GETINGE : signs T-DOC agreement with seven hospitals in Denmark
AQ
More news
News in other languages on GETINGE
02/04AVIS D'ANALYSTES DU JOUR : Orange, Iliad, Saint-Gobain, Vicat, Altice Europe, Gi..
01/30GETINGE : les prévisions 2020 jugées peu ambitieuses
2019Des hausses hétéroclites et des baisses venues du nord en 2019 en Europe
2019AVIS D'ANALYSTES DU JOUR : Société Générale, BNP Paribas, Hermès, Sika, Natixis,..
2019AVIS D'ANALYSTES DU JOUR : LVMH, Air France KLM, Natixis, Veolia, Adecco, Polyph..
More news
Analyst Recommendations on GETINGE
More recommendations
Sector news : Medical Equipment
02/1421 States Reject $18 Billion Offer From Drug Wholesalers to Settle Opioid Lit..
DJ
02/1421 States Reject $18 Billion Offer From Drug Wholesalers to Settle Opioid Lit..
DJ
02/1421 States Reject $18 Billion Offer From Drug Wholesalers to Settle Opioid Lit..
DJ
02/1421 States Reject $18 Billion Offer From Drug Wholesalers to Settle Opioid Lit..
DJ
02/13BAXTER INTERNATIONAL : Expects Restatement to Cut Income From Continuing Operati..
DJ
More sector news : Medical Equipment
Chart GETINGE
Duration : Period :
Getinge Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GETINGE
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 10
Average target price 162,10  SEK
Last Close Price 171,75  SEK
Spread / Highest target 16,4%
Spread / Average Target -5,62%
Spread / Lowest Target -36,0%
EPS Revisions
Managers
NameTitle
Mattias Sven Perjos President, Chief Executive Officer & Director
Johan Malmquist Chairman
Carl Reinhold Adolf Bennet Chairman
Lars Sandström Chief Financial Officer
Johan Bygge Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
GETINGE-2.93%4 816
ABBOTT LABORATORIES3.22%158 560
MASIMO CORPORATION16.14%9 841
NOVOCURE LIMITED10.55%9 220
ASAHI INTECC CO., LTD.-1.27%7 389
PENUMBRA, INC.15.93%6 649